Dietary supplement sales contract with KoDiscovery and Sales started in March

 NewG Lab Pharma, a 100% U.S. subsidiary of New G Lab, announced on February 14, 2020, that it has signed a KOfactor1 sales contract with KoDiscovery.

 KOfactor1, the first product of KOfactor Series, is a dietary supplement resulting from the know-how of Dr. Young-Hee Ko, and is combined with naturally occurring flavonoids and polyphenols extracted from green tea in a specific ratio. The formulation of natural compounds contained in KOfactor1 supports a powerful anti-cancer mechanism and anti-inflammatory function, and which is proved by not only exclusive experimental data from KoDiscovery Research Center but also existing scientific literature.

NewG Lab Pharma started selling KOfactor1 in March through the NewG Lab Pharma website.

Kofactor-Store